Back
Results - Announcements
Parnax Lab Ltd consolidated sales down 18.43% on year in Q2FY2026, net profit witnessed a sharp fall of 80.28%
14-Aug-2026, 07:35
Parnax Lab Ltd share price inched up 1.56% to Rs 133.05. The Company's net profit tumbled by 80.28% to Rs 0.43 crore, while revenue from operations reduced 18.43% to Rs 56.8 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, rising 4.63%. It has marginally improved by 0.66% over last one week and advanced by 11.20% in last one month while the market capitalization of Parnax Lab Ltd has slipped by 0.97% and 17.74% in the same period respectively. Profit before tax (PBT) of Parnax Lab Ltd stood at Rs 0.6 crore in Q2 FY26, tanking 86.55% year-on-year, and crashing by 80.00% quarter-on-quarter. EBITDA came in at Rs 4 crore, nosediving by 42.76% YoY and expanding by 43.10% sequentially. Total expenses reduced by 18.06% to Rs 54.72 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 33.44 crore, tumbling by 23.58% YoY, while employee benefits expense was at Rs 7.82 crore, rising by 8.61% YoY. For the TTM ended FY26, revenue from operations declined slightly by 0.51% to Rs 187.74 crore, while net profit rose by 19.96% to Rs 11.54 crore, compared to previous TTM. EBITDA jumped by 2214% to Rs 25.09 crore, and PBT jumped 30.04% to Rs 15.67 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 32.3 crore in FY26, as against Rs 15.88 crore in FY25. Parnax Lab Ltd ticked higher by 2.35% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.
Parnax Lab Ltd share price inched up 1.56% to Rs 133.05. The Company's net profit tumbled by 80.28% to Rs 0.43 crore, while revenue from operations reduced 18.43% to Rs 56.8 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, rising 4.63%. It has marginally improved by 0.66% over last one week and advanced by 11.20% in last one month while the market capitalization of Parnax Lab Ltd has slipped by 0.97% and 17.74% in the same period respectively. Profit before tax (PBT) of Parnax Lab Ltd stood at Rs 0.6 crore in Q2 FY26, tanking 86.55% year-on-year, and crashing by 80.00% quarter-on-quarter. EBITDA came in at Rs 4 crore, nosediving by 42.76% YoY and expanding by 43.10% sequentially. Total expenses reduced by 18.06% to Rs 54.72 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 33.44 crore, tumbling by 23.58% YoY, while employee benefits expense was at Rs 7.82 crore, rising by 8.61% YoY. For the TTM ended FY26, revenue from operations declined slightly by 0.51% to Rs 187.74 crore, while net profit rose by 19.96% to Rs 11.54 crore, compared to previous TTM. EBITDA jumped by 2214% to Rs 25.09 crore, and PBT jumped 30.04% to Rs 15.67 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 32.3 crore in FY26, as against Rs 15.88 crore in FY25. Parnax Lab Ltd ticked higher by 2.35% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.